Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy
about
Advances in understanding the molecular basis of the first steps in color visionIn vivo imaging of human cone photoreceptor inner segments.Outer retinal structure after closed-globe blunt ocular trauma.Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials.Curing color blindness--mice and nonhuman primatesChanges in outer retinal microstructures during six month period in eyes with acute zonal occult outer retinopathy-complexThree different cone opsin gene array mutational mechanisms with genotype-phenotype correlation and functional investigation of cone opsin variantsBlue cone monochromacy: visual function and efficacy outcome measures for clinical trials.Genotype-dependent variability in residual cone structure in achromatopsia: toward developing metrics for assessing cone healthAutofluorescence imaging with near-infrared excitation:normalization by reflectance to reduce signal from choroidal fluorophores.Outcome measure for the treatment of cone photoreceptor diseases: orientation to a scene with cone-only contrastTULP1 mutations causing early-onset retinal degeneration: preserved but insensitive macular cones.ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY.Evaluating Descriptive Metrics of the Human Cone MosaicDeveloping an Outcome Measure With High Luminance for Optogenetics Treatment of Severe Retinal Degenerations and for Gene Therapy of Cone DiseasesCone Photoreceptor Structure in Patients With X-Linked Cone Dysfunction and Red-Green Color Vision Deficiency.Residual Foveal Cone Structure in CNGB3-Associated Achromatopsia.Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations.EYS Mutations Causing Autosomal Recessive Retinitis Pigmentosa: Changes of Retinal Structure and Function with Disease Progression.Quantitative Assessment of Microstructural Changes of the Retina in Infants With Congenital Zika Syndrome.Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.The cone dysfunction syndromes.Overlap of abnormal photoreceptor development and progressive degeneration in Leber congenital amaurosis caused by NPHP5 mutation.Imaging Lenticular Autofluorescence in Older Subjects.Adaptive optics imaging of inherited retinal diseases.Non-invasive assessment of human cone photoreceptor function.Photoreceptor disruption and vision loss associated with central serous retinopathy.Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial.BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure.A 73,128 bp de novo deletion encompassing the OPN1LW/OPN1MW gene cluster in sporadic Blue Cone Monochromacy: a case report.Residual Cone Structure in Patients With X-Linked Cone Opsin Mutations
P2860
Q26799471-530F5DEC-8421-4E55-AF8E-298ED968779AQ33892926-76740953-A88D-4C42-964B-23479C2627B3Q34243600-8D15EAE5-F3B7-4184-91B1-77C08F27E303Q34323173-FC65D398-02C2-4FF4-BF32-1258B74289CBQ34400265-5A9CB1DD-065B-42B6-89A5-A4CE1BD20FA6Q34428354-06EAE8B2-5AF9-4D0C-AF73-93679A9EA882Q34435751-16039A63-F2AA-4334-B3B0-4E8AEB24FD26Q34473512-A475CFA1-17F5-4A60-BDDF-046F2EF669ADQ34531205-F650E1B9-4DAB-43BC-AE99-2412608422D1Q35682509-F885BA5A-400C-48DF-9D08-DDB9EA5C8749Q35740318-D5261A3C-C081-4199-844D-FE57336CF29AQ36086392-2AD7B179-23DE-4209-AEDD-20C2843979C0Q36830639-DCE7B6C1-A51C-4C4F-BAEE-5C18EADCB498Q36981680-190D4181-59AD-4360-9AED-435B6A3551D6Q37055754-2FFF69EC-973C-44EA-9069-96604505A086Q37142003-7BF37697-DF94-4108-8A46-686285F9B1C4Q37161357-8C753276-CB09-45C8-B67F-9C8EBF9E83D7Q37275303-CF058F65-BA1D-4F4E-8F48-02BE61518842Q38680672-BD1D443B-8C9F-4BD6-AE56-CFEB91DE6266Q40037684-07E1730A-94F5-480A-9C35-006B14C2EC8BQ41159206-1F4348D9-F776-4327-A9BE-AAA1000C90CCQ41225313-0FFE303B-57B5-4997-A033-1E8D60371C17Q41643474-6E6C81D3-A5E0-4122-AED7-8519B18151E9Q42280652-96F465F3-C1B3-4B83-AE64-F55D0645FD3BQ46250842-841FA3FD-A04C-455A-B9CF-AEBD3309BA5EQ47099707-97F3F7FB-CDA3-4268-B3B7-52CB4A521A92Q47140443-56133B18-DADA-4532-850D-CEE9681EBE8FQ47547418-7CD4D3CC-98B2-4E5E-BCD7-EABA73070BC5Q50086506-5D6C2A1C-5ACF-43F3-A346-9C7B5D06A3B1Q52728747-3E90FBDF-4A9B-4282-8806-BA440DE4E47CQ55483566-FE85CB42-CB27-43A9-AF5D-70DBF91F3B44Q58805549-0738079E-DE6E-4581-B098-0E60D628E75D
P2860
Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Human cone visual pigment dele ...... eptors to warrant gene therapy
@ast
Human cone visual pigment dele ...... eptors to warrant gene therapy
@en
Human cone visual pigment dele ...... eptors to warrant gene therapy
@nl
type
label
Human cone visual pigment dele ...... eptors to warrant gene therapy
@ast
Human cone visual pigment dele ...... eptors to warrant gene therapy
@en
Human cone visual pigment dele ...... eptors to warrant gene therapy
@nl
prefLabel
Human cone visual pigment dele ...... eptors to warrant gene therapy
@ast
Human cone visual pigment dele ...... eptors to warrant gene therapy
@en
Human cone visual pigment dele ...... eptors to warrant gene therapy
@nl
P2093
P2860
P50
P356
P1433
P1476
Human cone visual pigment dele ...... eptors to warrant gene therapy
@en
P2093
Alexander Sumaroka
Anthony T Moore
Artur V Cideciyan
Bernd Wissinger
Jessica C Gardner
Joseph Carroll
Megan Land
Michel Michaelides
Robert A Sisk
Sharon B Schwartz
P2860
P304
P356
10.1089/HUM.2013.153
P577
2013-10-30T00:00:00Z